<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37">
 <label>37.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Lua</surname>
    <given-names>LHL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Connors</surname>
    <given-names>NK</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sainsbury</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chuan</surname>
    <given-names>YP</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wibowo</surname>
    <given-names>N</given-names>
   </name>, 
   <name name-style="western">
    <surname>Middelberg</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <year>2014</year>
  <article-title>Bioengineering virus-like particles as vaccines</article-title>. 
  <source>Biotechnol Bioeng</source>
  <volume>111</volume>:
  <fpage>425</fpage>â€“
  <lpage>440</lpage>. doi:
  <pub-id pub-id-type="doi">10.1002/bit.25159</pub-id>.
  <pub-id pub-id-type="pmid">24347238</pub-id>
 </mixed-citation>
</ref>
